BACKGROUND: Leptospirosis and human immunodeficiency virus (HIV) infection are prevalent in many areas, including northern Tanzania, yet little is known about their interaction. METHODS: We enrolled febrile inpatients at two hospitals in Moshi, Tanzania, over 1 year and performed HIV antibody testing and the microscopic agglutination test (MAT) for leptospirosis. Confirmed leptospirosis was defined as ≥ four-fold rise in MAT titer between acute and convalescent serum samples, and probable leptospirosis was defined as any reciprocal MAT titer ≥ 800. RESULTS: Confirmed or probable leptospirosis was found in 70 (8.4%) of 831 participants with at least one serum sample tested. At total of 823 (99.0%) of 831 participants had HIV testing performed, and 203 (24.7%) were HIV infected. Among HIV-infected participants, 9 (4.4%) of 203 had confirmed or probable leptospirosis, whereas among HIV-uninfected participants 61 (9.8%) of 620 had leptospirosis. Leptospirosis was less prevalent among HIV-infected as compared to HIV-uninfected participants [odds ratio (OR) 0.43, p=0.019]. Among those with leptospirosis, HIV-infected patients more commonly presented with features of severe sepsis syndrome than HIV-uninfected patients, but differences were not statistically significant. Among HIV-infected patients, severe immunosuppression was not significantly different between those with and without leptospirosis (p=0.476). Among HIV-infected adolescents and adults, median CD4 percent and median CD4 count were higher among those with leptospirosis as compared to those with other etiologies of febrile illness, but differences in CD4 count did not reach statistical significance (p=0.015 and p=0.089, respectively). CONCLUSIONS: Among febrile inpatients in northern Tanzania, leptospirosis was not more prevalent among HIV-infected patients. Although some indicators of leptospirosis severity were more common among HIV-infected patients, a statistically significant difference was not demonstrated. Among HIV-infected patients, those with leptospirosis were not more immunosuppressed relative to those with other etiologies of febrile illness.
BACKGROUND:Leptospirosis and human immunodeficiency virus (HIV) infection are prevalent in many areas, including northern Tanzania, yet little is known about their interaction. METHODS: We enrolled febrile inpatients at two hospitals in Moshi, Tanzania, over 1 year and performed HIV antibody testing and the microscopic agglutination test (MAT) for leptospirosis. Confirmed leptospirosis was defined as ≥ four-fold rise in MAT titer between acute and convalescent serum samples, and probable leptospirosis was defined as any reciprocal MAT titer ≥ 800. RESULTS: Confirmed or probable leptospirosis was found in 70 (8.4%) of 831 participants with at least one serum sample tested. At total of 823 (99.0%) of 831 participants had HIV testing performed, and 203 (24.7%) were HIV infected. Among HIV-infectedparticipants, 9 (4.4%) of 203 had confirmed or probable leptospirosis, whereas among HIV-uninfectedparticipants 61 (9.8%) of 620 had leptospirosis. Leptospirosis was less prevalent among HIV-infected as compared to HIV-uninfectedparticipants [odds ratio (OR) 0.43, p=0.019]. Among those with leptospirosis, HIV-infectedpatients more commonly presented with features of severe sepsis syndrome than HIV-uninfectedpatients, but differences were not statistically significant. Among HIV-infectedpatients, severe immunosuppression was not significantly different between those with and without leptospirosis (p=0.476). Among HIV-infected adolescents and adults, median CD4 percent and median CD4 count were higher among those with leptospirosis as compared to those with other etiologies of febrile illness, but differences in CD4 count did not reach statistical significance (p=0.015 and p=0.089, respectively). CONCLUSIONS: Among febrile inpatients in northern Tanzania, leptospirosis was not more prevalent among HIV-infectedpatients. Although some indicators of leptospirosis severity were more common among HIV-infectedpatients, a statistically significant difference was not demonstrated. Among HIV-infectedpatients, those with leptospirosis were not more immunosuppressed relative to those with other etiologies of febrile illness.
Authors: Mary D Bajani; David A Ashford; Sandra L Bragg; Christopher W Woods; Tin Aye; Richard A Spiegel; Brian D Plikaytis; Bradley A Perkins; Maureen Phelan; Paul N Levett; Robbin S Weyant Journal: J Clin Microbiol Date: 2003-02 Impact factor: 5.948
Authors: Holly M Biggs; Duy M Bui; Renee L Galloway; Robyn A Stoddard; Sean V Shadomy; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; John A Crump Journal: Am J Trop Med Hyg Date: 2011-08 Impact factor: 2.345
Authors: M V da Silva; L Batista; E D Camargo; P A Leitão; V G Szalkay; C Rosenthal; A J Vaz; A M de Souza Journal: Rev Soc Bras Med Trop Date: 1990 Oct-Dec Impact factor: 1.581
Authors: Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay Journal: Crit Care Med Date: 2003-04 Impact factor: 7.598
Authors: Lesley E Scott; John A Crump; Emma Msuya; Anne B Morrissey; Willem F Venter; Wendy S Stevens Journal: J Virol Methods Date: 2010-12-21 Impact factor: 2.014
Authors: John A Crump; Habib O Ramadhani; Anne B Morrissey; Levina J Msuya; Lan-Yan Yang; Shein-Chung Chow; Susan C Morpeth; Hugh Reyburn; Boniface N Njau; Andrea V Shaw; Helmut C Diefenthal; John A Bartlett; John F Shao; Werner Schimana; Coleen K Cunningham; Grace D Kinabo Journal: Trop Med Int Health Date: 2011-04-07 Impact factor: 2.622
Authors: Ann M Buchanan; Florida J Muro; Jean Gratz; John A Crump; Augustine M Musyoka; Moses W Sichangi; Anne B Morrissey; Jane K M'rimberia; Boniface N Njau; Levina J Msuya; John A Bartlett; Coleen K Cunningham Journal: Trop Med Int Health Date: 2010-07-15 Impact factor: 2.622
Authors: G L Chaters; P C D Johnson; S Cleaveland; J Crispell; W A de Glanville; T Doherty; L Matthews; S Mohr; O M Nyasebwa; G Rossi; L C M Salvador; E Swai; R R Kao Journal: Philos Trans R Soc Lond B Biol Sci Date: 2019-07-08 Impact factor: 6.237
Authors: Christine Hercik; Leonard Cosmas; Ondari D Mogeni; Wanze Kohi; Sayoki Mfinanga; Christopher Loffredo; Joel M Montgomery Journal: Am J Trop Med Hyg Date: 2019-07 Impact factor: 2.345
Authors: Christopher C Moore; Shevin T Jacob; Patrick Banura; Jixian Zhang; Suzanne Stroup; David R Boulware; W Michael Scheld; Eric R Houpt; Jie Liu Journal: Clin Infect Dis Date: 2019-01-07 Impact factor: 9.079
Authors: Brian T Backstedt; Ozlem Buyuktanir; Janet Lindow; Elsio A Wunder; Mitermayer G Reis; Sahar Usmani-Brown; Michel Ledizet; Albert Ko; Utpal Pal Journal: PLoS One Date: 2015-06-19 Impact factor: 3.240
Authors: Shabani Kiyabo Motto; Gabriel Mkilema Shirima; Barend Mark de Clare Bronsvoort; Elizabeth Anne Jessie Cook Journal: PLoS Negl Trop Dis Date: 2021-11-16
Authors: Elizabeth Anne Jessie Cook; William Anson de Glanville; Lian Francesca Thomas; Samuel Kariuki; Barend Mark de Clare Bronsvoort; Eric Maurice Fèvre Journal: Occup Environ Med Date: 2016-12-02 Impact factor: 4.402